Medifast
Financial ratios & Valuation

Forward Multiples (2025 – 2025)

2025
Price/Earnings ratio
9.04
Price/Sales ratio
0.25
Earnings per Share (EPS)
$1.56

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
32.2518.1127.6430.0226.7716.5522.4614.948.997.353.0316.55
Price/Sales ratio
1.491.331.792.762.981.802.471.600.800.680.221.80
Price/Book Value ratio
5.284.105.137.6613.6812.3014.6912.108.323.630.9712.30
Price/Cash Flow ratio
16.6412.3519.4419.2524.5515.3015.9125.926.634.952.2615.30
Price/Free Cash Flow ratio
22.9613.6621.9320.8126.7317.3816.5840.627.255.182.4317.38
Price/Earnings Growth ratio
-0.800.29-2.730.550.260.390.700.24-1.05-0.250.190.39
Dividend Yield
N/AN/A2.41%1.84%1.55%2.74%2.30%2.60%5.54%9.98%8.74%1.55%
Profitability Indicator Ratios
Gross Profit Margin
73.33%73.80%74.91%75.54%75.82%75.22%74.64%73.88%71.33%72.37%73.15%75.22%
Operating Profit Margin
10.60%10.51%9.78%13.14%13.78%12.75%14.35%14.16%11.56%11.79%9.00%12.75%
Pretax Profit Margin
11.10%10.87%9.87%13.37%14.08%12.94%14.36%14.16%11.51%12.01%9.69%12.94%
Net Profit Margin
4.62%7.35%6.49%9.19%11.13%10.91%11.00%10.74%8.98%9.27%7.54%10.91%
Effective Tax Rate
33.64%34.05%34.24%31.25%20.92%15.64%23.39%24.10%21.99%22.81%22.16%20.92%
Return on Assets
11.37%17.09%14.71%18.99%32.92%40.02%37.25%41.18%45.40%32.07%22.38%40.02%
Return On Equity
16.37%22.64%18.57%25.53%51.13%74.32%65.41%81.01%92.59%49.34%34.26%74.32%
Return on Capital Employed
33.99%30.59%27.74%36.43%63.29%78.98%81.43%94.63%105.41%58.08%35.83%78.98%
Liquidity Ratios
Current Ratio
3.043.734.143.372.411.942.10N/AN/AN/A2.842.41
Quick Ratio
2.453.173.392.851.761.321.620.740.731.832.021.76
Cash ratio
0.901.782.142.021.340.961.470.610.621.021.261.26
Days of Sales Outstanding
2.112.181.840.690.730.730.22N/AN/AN/AN/A0.73
Days of Inventory outstanding
75.4968.1197.0495.65117.20100.6782.21164.9194.6867.2770.06100.67
Operating Cycle
77.6070.2998.8896.35117.94101.4182.44164.9194.6867.2770.06101.41
Days of Payables Outstanding
58.4257.5350.7768.2857.3146.6755.5764.9342.3148.29107.8557.31
Cash Conversion Cycle
19.1712.7648.1128.0760.6254.7426.8699.9752.3618.97-37.7854.74
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/A0.04N/A0.080.010.06N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/A0.07N/A0.160.020.09N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/A0.04N/A0.11N/A0.06N/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/A0.06N/A0.140.020.08N/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A29.73N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/A13.00N/A7.4625.094.41N/A
Company Equity Multiplier
1.441.321.261.341.551.851.751.962.031.531.431.85
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.080.100.090.140.120.110.150.060.120.130.100.11
Free Cash Flow / Operating Cash Flow Ratio
0.720.900.880.920.910.880.950.630.910.950.930.91
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/A13.00N/A7.4625.094.41N/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/A39.53N/A33.6825.0915.25N/A
Dividend Payout Ratio
N/AN/A66.66%55.51%41.51%45.42%51.71%38.92%49.88%73.44%80.52%41.51%